Launch of Egoo Innovate attracts attention at AACC/Clinical Lab

Expo Interest indicates good market fit

On July 25-27-2023, Qlife was exhibiting at the AACC/Clinical Lab Expo/ADLM (American Association for Clinical Chemistry/Association for Diagnostics & Laboratory Medicine) in Anaheim, California, and Egoo Innovate as an open system was officially launched.

A press conference for trade media was the kick-off, to generate editorial interest. No video was recorded.

At AACC/Clinical Lab Expo, the open system Egoo Innovate was launched and Qlife demonstrated how Egoo Innovate can be a game-changer in promoting faster and targeted implementation of critical biomarker assays into at-home testing. Participants in the conference were curious and inquisitive on the potential of the unique technology and how the open system will work for different stakeholders.

“At AACC/ADML, we were able to attract and access the world’s largest diagnostics market as well as trade media. The launch of Egoo Innovate is well-timed and the interest for implementing biomarkers on Egoo Innovate, from follow-up conversations and visitors to our booth, indicates a good market fit. Now, we can start conversations with prospective customers and partners, and potentially play a key role in the acceleration of development of new biomarkers for home-testing. We expect participation to generate new opportunities,” says Thomas Warthoe, CEO of Qlife.

See presentation in the attached.

For more information please contact:

Thomas Warthoe, CEO
tw@egoo.health
+45 21 63 35 34

Qlife is a medical device company born to challenge the status quo in healthcare. We work to shift the perspective and turn today’s view on healthcare into tomorrow’s focus on health- empowerment. We are on a quest to empower people with more accessible ways to understand their health – so that they can move beyond reactive care towards proactive wellbeing. It’s how we contribute to improving quality of life for every individual and for the greater society.

Shares for Qlife are being traded on Nasdaq First North Growth Market in Stockholm with G&W Fondkommission as certified advisor.
Read more on Egoo.health, Qlifeholding.com or follow us on LinkedIn.